Financhill
Back

Metagenomi 10K Form

Sell
48

MGX
Metagenomi

Last Price:
$2.13
Seasonality Move:
-50.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MGX News And Ratings

See the #1 stock for the next 7 days that we like better than MGX

MGX Financial Statistics

Sales & Book Value

Annual Sales: $52.3M
Cash Flow: $-23.1M
Price / Cash Flow: 0
Annual Sales: $5.69
Price / Book: 0.37

Profitability

EPS (TTM): -2.11000
Net Income (TTM): $-77.9M
Gross Margin: --
Return on Equity: -31.22%
Return on Assets: -21.87%

Metagenomi Earnings Forecast

Key Metagenomi Financial Ratios

  • The Research & Development expenses have been 208.78% of Revenue.
  • The Net Earning history of MGX is -149.26% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

Metagenomi Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MGX
Website: metagenomi.co

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.85
Quick Ratio: 5.69

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MGX Technical Analysis vs Fundamental Analysis

Sell
48
Metagenomi (MGX) is a Sell

Is Metagenomi a Buy or a Sell?

  • Metagenomi stock is rated a Sell
    The current Metagenomi [MGX] share price is $2.10. The Score for MGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.